30 studies found for:    weill AND injection medications | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration
Conditions: Hypogonadism;   Opioid-Related Disorders;   Male Infertility
Interventions: Drug: Clomiphene citrate;   Drug: Placebo
2 Not yet recruiting Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma
Condition: Hilar Cholangiocarcinoma
Interventions: Drug: Photodynamic therapy-Photofrin;   Procedure: Stenting procedure;   Drug: Chemotherapy regimen Gemcitabine/Cisplatin
3 Recruiting BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors
Conditions: Metastatic Cancer;   Cancer;   Refractory Solid Tumor
Interventions: Drug: BP31510 monotherapy;   Drug: BP31510 in combination with chemotherapy
4 Recruiting Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein Occlusion
Condition: Central Retinal Vein Occlusion
Intervention: Drug: Tissue Plasminogen Activator
5 Unknown  Botox for the Treatment of Overactive Bladder Secondary to Benign Prostatic Obstruction
Condition: Overactive Bladder
Intervention: Drug: Botox/Placebo
6 Recruiting Pegylated Interferon Alpha-2b in Early Primary Myelofibrosis
Condition: Myelofibrosis
Intervention: Drug: Peginterferon alfa-2a
7 Recruiting Clinical Trials to Reduce the Risk of Antimicrobial Resistance
Condition: Bacterial Pneumonia
Interventions: Drug: IV meropenem; parenteral aminoglycoside;   Drug: I.V. Meropenem
8 Recruiting Intra-operative Use of Indigo Carmine Dye for the Delineation of Ill Defined Tumor Borders Using Stereotactic Injection
Condition: Brain Tumors With Ill-defined Margins
Intervention: Drug: Indigo carmine
9 Recruiting A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours
Conditions: Carcinoid Tumor of the Small Bowel;   Neuroendocrine Tumour
Interventions: Drug: Octreotide;   Drug: 177Lu-DOTA0-Tyr3-Octreotate
10 Recruiting Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
Condition: High Risk Acute Myeloid Leukemia
Interventions: Drug: CPX-351;   Drug: 7+3 (cytarabine and daunorubicin)
11 Unknown  Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer
Conditions: Esophageal Cancer;   Malignant Neoplasm of Cardio-esophageal Junction of Stomach
Interventions: Drug: Azacitidine;   Drug: Oxaliplatin;   Drug: Epirubicin;   Drug: Capecitabine
12 Recruiting Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Angioedema
Condition: Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Interventions: Drug: Icatibant;   Drug: Placebo
13 Recruiting Study to Investigate Idelalisib in Combination With Chemotherapeutic Agents, Immunomodulatory Agents and Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
Conditions: Indolent Non-Hodgkin's Lymphoma;   Chronic Lymphocytic Leukemia;   Mantle Cell Lymphoma
Interventions: Drug: Idelalisib;   Drug: Rituximab;   Drug: Bendamustine;   Drug: Ofatumumab;   Drug: Fludarabine;   Drug: Everolimus;   Drug: Bortezomib;   Drug: Chlorambucil;   Drug: Lenalidomide
14 Recruiting Phase 3 Study With Carfilzomib and Dexamethasone Versus Velcade and Dexamethasone for Relapsed Multiple Myeloma Patients
Condition: Multiple Myeloma
Interventions: Drug: Carfilzomib plus dexamethasone;   Drug: Velcade plus dexamethasone
15 Recruiting Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
Condition: HER2 Low to Intermediate Breast Cancer
Interventions: Biological: NeuVax™ vaccine;   Biological: Leukine® (sargramostim, GM-CSF) and water for injection
16 Unknown  Combination Veltuzumab and Fractionated 90Y- Epratuzumab Radioimmunotherapy in Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: 90Y-epratuzumab tetraxetan;   Biological: veltuzumab
17 Recruiting Trial of Erythropoietin Neuroprotection in Extremely Preterm Infants
Condition: Extreme Prematurity
Intervention: Drug: Epo
18 Recruiting Photodynamic Therapy (PDT) Cholangiocarcinoma Registry
Conditions: Unresectable Cholangiocarcinoma;   Biliary Obstruction;   Stent Obstruction;   Biliary Stricture
Intervention: Procedure: Photodynamic Therapy
19 Recruiting Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
Conditions: Glioblastoma;   Small Cell Glioblastoma;   Giant Cell Glioblastoma;   Gliosarcoma;   Glioblastoma With Oligodendroglial Component
Interventions: Drug: Rindopepimut (CDX-110) with GM-CSF;   Drug: Temozolomide;   Drug: KLH
20 Recruiting Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
Condition: Dumping Syndrome Patients
Intervention: Drug: SOM230

Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results
Indicates status has not been verified in more than two years